| 2.160 -0.098 (-4.34%) 10-16 17:35 |
|
| Open: | 2.260 |
| High: | 2.260 |
| Low: | 2.160 |
| Pre. close: | 2.258 |
| Volume: | 172,095 |
| Avg. volume: | 135,796 |
| MA (50): | 2.751 |
| MA (200): | 3.598 |
| Year high: | 6.480 |
| Year low: | 2.010 |
| Market cap: | 51(M) |
| EPS: | -1.69 |
| PE ratio: | -1.28 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Sat, 17 Oct 2026
6OP.HM interactive stock chart | OSE Immunotherapeutics S.A. A stock - Yahoo Finance Australia
Thu, 15 Oct 2026
OSE Immunotherapeutics to Present at Chardan’s 10th Annual Healthcare Conference - GlobeNewswire
Tue, 29 Sep 2026
Diluted shares outstanding of OSE Immunotherapeutics SA – HAN:6OP - TradingView
Mon, 28 Sep 2026
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2026, and Provides Business Update - GlobeNewswire
Wed, 23 Sep 2026
OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting - GlobeNewswire
Wed, 09 Sep 2026
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients - Yahoo Finance UK
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.